Stock Analysis on Net

AbbVie Inc. (NYSE:ABBV)

$24.99

Adjusted Financial Ratios

Microsoft Excel

Adjusted Financial Ratios (Summary)

AbbVie Inc., adjusted financial ratios

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Activity Ratio
Total Asset Turnover
Reported
Adjusted
Solvency Ratios
Debt to Equity
Reported
Adjusted
Debt to Capital
Reported
Adjusted
Financial Leverage
Reported
Adjusted
Profitability Ratios
Net Profit Margin
Reported
Adjusted
Return on Equity (ROE)
Reported
Adjusted
Return on Assets (ROA)
Reported
Adjusted

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


An examination of the adjusted financial ratios reveals several notable trends between 2021 and 2025. Asset turnover, both reported and adjusted, generally increased over the period, suggesting improving efficiency in asset utilization. However, leverage ratios experienced significant fluctuations, and profitability metrics demonstrate a complex pattern of change.

Asset Turnover
The adjusted total asset turnover ratio exhibited a consistent, albeit modest, upward trend, increasing from 0.39 in 2021 to 0.48 in 2025. This indicates a gradual improvement in the company’s ability to generate sales from its assets. The reported ratio follows a similar pattern, remaining close to the adjusted value.
Leverage Ratios
Both the adjusted debt to equity and debt to capital ratios increased substantially from 2021 to 2024. The adjusted debt to equity ratio rose dramatically from 4.71 to 123.00, while the adjusted debt to capital ratio increased from 0.82 to 0.99. This suggests a significant increase in financial leverage. The reported ratios show similar, though less extreme, increases. Data for 2025 is incomplete, but the trend suggests continued high leverage.
Adjusted financial leverage also experienced a substantial increase, rising from 8.76 in 2021 to 234.24 in 2024. This mirrors the trend observed in the debt ratios, indicating a considerable reliance on debt financing. Again, 2025 data is missing.
Profitability
The adjusted net profit margin decreased significantly from 19.00% in 2021 to 3.38% in 2023, before partially recovering to 7.52% in 2025. This indicates a substantial decline in profitability, followed by a recent improvement. The reported net profit margin shows a similar, though less pronounced, pattern.
Adjusted return on equity (ROE) followed a volatile pattern. It decreased sharply from 64.89% in 2021 to 26.84% in 2023, then increased dramatically to 581.19% in 2024. The reported ROE also shows a similar pattern of decline and subsequent surge. The large fluctuations in ROE are likely linked to the changes in leverage and net profit margin.
The adjusted return on assets (ROA) decreased from 7.40% in 2021 to 1.42% in 2023, then increased to 3.60% in 2025. This trend suggests a decline in the efficiency of asset utilization in generating profits, followed by a recent recovery. The reported ROA exhibits a similar pattern.

In summary, the period under review was characterized by increasing asset turnover, a substantial rise in financial leverage, and fluctuating profitability. The significant increases in leverage ratios, coupled with the initial decline in profitability metrics, warrant further investigation. The recent recovery in profitability, however, provides a potentially positive signal.


AbbVie Inc., Financial Ratios: Reported vs. Adjusted


Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Reported
Selected Financial Data (US$ in millions)
Net revenues
Total assets
Activity Ratio
Total asset turnover1
Adjusted
Selected Financial Data (US$ in millions)
Net revenues
Adjusted total assets2
Activity Ratio
Adjusted total asset turnover3

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Total asset turnover = Net revenues ÷ Total assets
= ÷ =

2 Adjusted total assets. See details »

3 2025 Calculation
Adjusted total asset turnover = Net revenues ÷ Adjusted total assets
= ÷ =


The period between December 31, 2021, and December 31, 2025, demonstrates fluctuating performance in revenue generation relative to asset utilization. Net revenues initially increased before experiencing a decline, while total assets generally decreased over the five-year period. Analysis of both reported and adjusted total asset turnover ratios reveals insights into the efficiency with which assets are employed to generate sales.

Net Revenues
Net revenues increased from US$56,197 million in 2021 to US$58,054 million in 2022, representing a growth of approximately 3.3%. A subsequent decrease was observed in 2023, with revenues falling to US$54,318 million. Revenues partially recovered in 2024, reaching US$56,334 million, and continued to rise in 2025 to US$61,160 million, indicating a positive trend in the latter part of the analyzed period.
Total Assets
Total assets exhibited a consistent downward trend throughout the period. Beginning at US$146,529 million in 2021, assets decreased to US$138,805 million in 2022, US$134,711 million in 2023, and US$135,161 million in 2024. This decline continued into 2025, with assets reaching US$133,960 million. The reduction in asset base suggests potential asset sales, depreciation, or write-downs.
Reported Total Asset Turnover
The reported total asset turnover ratio showed initial improvement, increasing from 0.38 in 2021 to 0.42 in 2022 and remaining at 0.42 in 2023. A slight increase to 0.43 was noted in 2024, followed by a more substantial rise to 0.46 in 2025. This indicates increasing efficiency in generating revenue from the reported asset base towards the end of the period.
Adjusted Total Assets & Turnover
Adjusted total assets followed a similar decreasing trend to the reported total assets, starting at US$144,255 million in 2021 and declining to US$127,856 million in 2025. The adjusted total asset turnover ratio mirrored the trend of the reported ratio, increasing from 0.39 in 2021 to 0.43 in 2022, 0.42 in 2023, 0.43 in 2024, and reaching 0.48 in 2025. The adjusted ratio consistently remained slightly higher than the reported ratio throughout the period. The convergence of the reported and adjusted ratios suggests that the adjustments made to total assets did not significantly alter the overall assessment of asset utilization efficiency.

Overall, despite a decrease in the asset base, the asset turnover ratios demonstrate an improving trend in revenue generation efficiency, particularly in the final two years of the analyzed period. The consistent increase in the adjusted total asset turnover ratio suggests that the company is becoming more effective at utilizing its assets to generate sales, even after accounting for adjustments to the asset value.


Adjusted Debt to Equity

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Reported
Selected Financial Data (US$ in millions)
Total debt
Stockholders’ equity (deficit)
Solvency Ratio
Debt to equity1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted total debt2
Adjusted total equity (deficit)3
Solvency Ratio
Adjusted debt to equity4

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Debt to equity = Total debt ÷ Stockholders’ equity (deficit)
= ÷ =

2 Adjusted total debt. See details »

3 Adjusted total equity (deficit). See details »

4 2025 Calculation
Adjusted debt to equity = Adjusted total debt ÷ Adjusted total equity (deficit)
= ÷ =


The information presents a five-year trend of debt and equity figures, culminating in calculated debt-to-equity ratios, both reported and adjusted. A notable shift in the financial leverage is observed over the period.

Total Debt
Total debt decreased from $76,684 million in 2021 to $63,271 million in 2022, and continued a slight downward trend to $59,385 million in 2023. However, debt levels increased in subsequent years, reaching $67,144 million in 2024 and $67,496 million in 2025. The increases in 2024 and 2025, while not substantial, reverse the prior downward trajectory.
Stockholders’ Equity
Stockholders’ equity initially increased from $15,408 million in 2021 to $17,254 million in 2022. A significant decline then commenced, falling to $10,360 million in 2023, $3,325 million in 2024, and ultimately resulting in a deficit of -$3,270 million in 2025. This represents a substantial erosion of equity over the latter part of the observed period.
Reported Debt-to-Equity Ratio
The reported debt-to-equity ratio reflects the changes in both debt and equity. It decreased from 4.98 in 2021 to 3.67 in 2022, then increased to 5.73 in 2023. A dramatic increase is then observed, rising to 20.19 in 2024, with a value for 2025 not provided. This escalation correlates with the declining equity position.
Adjusted Total Debt
Adjusted total debt follows a similar pattern to total debt, decreasing from $77,575 million in 2021 to $64,191 million in 2022, then $60,286 million in 2023. It then increased to $68,019 million in 2024 and $68,379 million in 2025. The magnitude of change is relatively consistent with the trends observed in total debt.
Adjusted Total Equity
Adjusted total equity mirrors the trend of stockholders’ equity, increasing from $16,459 million in 2021 to $16,740 million in 2022, then declining sharply to $6,833 million in 2023, $553 million in 2024, and finally becoming a deficit of -$6,629 million in 2025. The adjusted equity figures demonstrate a similar pattern of erosion as the reported equity.
Adjusted Debt-to-Equity Ratio
The adjusted debt-to-equity ratio decreased from 4.71 in 2021 to 3.83 in 2022, increased to 8.82 in 2023, and then experienced a substantial increase to 123.00 in 2024. A value for 2025 is not provided. The significant increase in 2024 is directly attributable to the substantial decline in adjusted equity and the relatively stable adjusted debt levels.

The trend indicates a growing reliance on debt financing relative to equity, particularly pronounced in 2024. The shift from positive equity to a deficit position in 2025, based on the available information, suggests a considerable weakening of the equity base.


Adjusted Debt to Capital

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Reported
Selected Financial Data (US$ in millions)
Total debt
Total capital
Solvency Ratio
Debt to capital1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted total debt2
Adjusted total capital3
Solvency Ratio
Adjusted debt to capital4

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =

2 Adjusted total debt. See details »

3 Adjusted total capital. See details »

4 2025 Calculation
Adjusted debt to capital = Adjusted total debt ÷ Adjusted total capital
= ÷ =


The reported and adjusted debt to capital ratios exhibit increasing leverage over the observed five-year period. While both metrics initially remain relatively stable, a clear upward trend emerges in the later years. Total debt decreased from 2021 to 2022, then remained relatively flat through 2023, before increasing in 2024 and 2025. Total capital experienced a more pronounced decline, particularly from 2021 to 2023, with a slight recovery in 2024 followed by a further decrease in 2025. The adjustments to total debt and capital appear to amplify the observed trends.

Reported Debt to Capital
The reported debt to capital ratio began at 0.83 in 2021 and decreased slightly to 0.79 in 2022. It then increased to 0.85 in 2023, continuing upward to 0.95 in 2024, and reaching 1.05 in 2025. This indicates a growing proportion of debt financing relative to total capital.
Adjusted Debt to Capital
The adjusted debt to capital ratio mirrored the trend of the reported ratio, starting at 0.82 in 2021 and decreasing to 0.79 in 2022. It rose to 0.90 in 2023, then to 0.99 in 2024, and culminated at 1.11 in 2025. The adjusted ratio consistently indicates a higher level of leverage than the reported ratio, suggesting the adjustments increase the calculated debt burden.
Total Debt and Capital Trends
Total debt decreased from US$76,684 million in 2021 to US$63,271 million in 2022, then stabilized around US$60 billion for 2023, before increasing to US$67,144 million in 2024 and US$67,496 million in 2025. Total capital experienced a more substantial decline, falling from US$92,092 million in 2021 to US$69,745 million in 2023, with a modest increase to US$70,469 million in 2024, and a further decrease to US$64,226 million in 2025. The combined effect of decreasing capital and fluctuating debt levels drives the observed increase in both reported and adjusted debt to capital ratios.

The consistent increase in the adjusted debt to capital ratio, exceeding the reported ratio, suggests that the adjustments applied to the debt and capital figures are materially impacting the assessment of the company’s financial leverage. Further investigation into the nature of these adjustments would be beneficial to fully understand their implications.


Adjusted Financial Leverage

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Reported
Selected Financial Data (US$ in millions)
Total assets
Stockholders’ equity (deficit)
Solvency Ratio
Financial leverage1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted total assets2
Adjusted total equity (deficit)3
Solvency Ratio
Adjusted financial leverage4

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Financial leverage = Total assets ÷ Stockholders’ equity (deficit)
= ÷ =

2 Adjusted total assets. See details »

3 Adjusted total equity (deficit). See details »

4 2025 Calculation
Adjusted financial leverage = Adjusted total assets ÷ Adjusted total equity (deficit)
= ÷ =


The financial leverage metrics exhibit significant fluctuations over the observed period. Total assets generally decreased from 2021 to 2025, while stockholders’ equity experienced a substantial decline, culminating in a deficit by the end of 2025. These movements are reflected in both the reported and adjusted financial leverage ratios.

Reported Financial Leverage
Reported financial leverage decreased from 9.51 in 2021 to 8.04 in 2022. A considerable increase is then observed, rising to 13.00 in 2023 and escalating dramatically to 40.65 in 2024. The ratio’s value for 2025 is not available.
Adjusted Financial Leverage
Adjusted financial leverage followed a similar pattern to the reported ratio, though with different magnitudes. It decreased slightly from 8.76 in 2021 to 8.11 in 2022. An increase to 18.87 in 2023 is noted, followed by a substantial surge to 234.24 in 2024. The ratio’s value for 2025 is not available.

The adjusted total assets and adjusted total equity (deficit) also show a declining trend. Adjusted total assets decreased steadily from US$144,255 million in 2021 to US$127,856 million in 2025. Adjusted total equity decreased from US$16,459 million in 2021, becoming a deficit of US$6,629 million by 2025. This decline in equity, coupled with the relatively stable asset base, is a primary driver of the increasing leverage ratios.

Equity Trend
The decline in both stockholders’ equity and adjusted total equity is a significant observation. The transition from positive equity to a deficit position in 2025 suggests potential concerns regarding the company’s financial health and solvency. This trend warrants further investigation into the underlying causes, such as accumulated losses, share repurchases, or dividend payments.

The substantial increases in both reported and adjusted financial leverage in 2024 indicate a significant increase in the company’s reliance on debt financing relative to equity. The absence of a 2025 value for both leverage ratios prevents a complete assessment of the trend, but the 2024 figures suggest a potentially precarious financial position.


Adjusted Net Profit Margin

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Reported
Selected Financial Data (US$ in millions)
Net earnings attributable to AbbVie Inc.
Net revenues
Profitability Ratio
Net profit margin1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted net earnings2
Net revenues
Profitability Ratio
Adjusted net profit margin3

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
Net profit margin = 100 × Net earnings attributable to AbbVie Inc. ÷ Net revenues
= 100 × ÷ =

2 Adjusted net earnings. See details »

3 2025 Calculation
Adjusted net profit margin = 100 × Adjusted net earnings ÷ Net revenues
= 100 × ÷ =


The adjusted net profit margin exhibited considerable fluctuation between 2021 and 2025. Initial values were relatively high, followed by a significant decline and subsequent recovery. A detailed examination of the trends is presented below.

Adjusted Net Profit Margin - Overall Trend
The adjusted net profit margin began at 19.00% in 2021, decreased to 18.27% in 2022, and then experienced a substantial drop to 3.38% in 2023. A recovery was observed in 2024, with the margin increasing to 5.71%, and continued into 2025, reaching 7.52%. This indicates a period of profitability challenges followed by a return towards previous levels.
Comparison with Reported Net Profit Margin
The adjusted net profit margin consistently remained below the reported net profit margin across all observed years. The difference between the two margins widened considerably in 2023 and 2024, suggesting that adjustments significantly impacted reported profitability during those periods. The gap narrowed somewhat in 2025, but the adjusted margin still remained lower.
Relationship to Net Revenues
Net revenues generally increased over the period, rising from US$56,197 million in 2021 to US$61,160 million in 2025. However, the increase in net revenues did not consistently translate into a corresponding increase in adjusted net earnings. The substantial decline in the adjusted net profit margin in 2023 occurred despite a decrease in net revenues, indicating that cost of goods sold or operating expenses likely increased disproportionately.
Adjusted Net Earnings
Adjusted net earnings mirrored the trend observed in the adjusted net profit margin. Earnings decreased from US$10,680 million in 2021 to US$1,834 million in 2023, before increasing to US$3,214 million in 2024 and further to US$4,600 million in 2025. This suggests that the factors influencing the adjusted net profit margin directly impacted the absolute level of adjusted net earnings.

In summary, the period under review was characterized by volatility in adjusted profitability. While a recovery is evident in the later years, the significant decline in 2023 warrants further investigation to understand the underlying drivers of the adjustment and their impact on the company’s financial performance.


Adjusted Return on Equity (ROE)

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Reported
Selected Financial Data (US$ in millions)
Net earnings attributable to AbbVie Inc.
Stockholders’ equity (deficit)
Profitability Ratio
ROE1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted net earnings2
Adjusted total equity (deficit)3
Profitability Ratio
Adjusted ROE4

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
ROE = 100 × Net earnings attributable to AbbVie Inc. ÷ Stockholders’ equity (deficit)
= 100 × ÷ =

2 Adjusted net earnings. See details »

3 Adjusted total equity (deficit). See details »

4 2025 Calculation
Adjusted ROE = 100 × Adjusted net earnings ÷ Adjusted total equity (deficit)
= 100 × ÷ =


The adjusted return on equity (ROE) exhibited considerable fluctuation between 2021 and 2023, followed by a substantial increase in 2024. This analysis details the observed trends in adjusted ROE and its underlying components.

Adjusted ROE Trend
Adjusted ROE began at 64.89% in 2021, decreased to 63.38% in 2022, and experienced a significant decline to 26.84% in 2023. A dramatic increase to 581.19% was then observed in 2024. The value for 2025 is not available for comparison.
Adjusted Net Earnings
Adjusted net earnings decreased from US$10,680 million in 2021 to US$10,609 million in 2022, representing a slight decline. A substantial decrease to US$1,834 million occurred in 2023. Earnings then increased to US$3,214 million in 2024 and further to US$4,600 million in 2025.
Adjusted Total Equity
Adjusted total equity showed an initial increase from US$16,459 million in 2021 to US$16,740 million in 2022. A considerable decrease to US$6,833 million was noted in 2023, followed by a further reduction to US$553 million in 2024. Equity then became negative, reaching a deficit of US$6,629 million in 2025.
Relationship between Adjusted ROE Components
The decline in adjusted ROE from 2021 to 2023 appears to be driven by a combination of decreasing adjusted net earnings and decreasing adjusted total equity. The substantial increase in adjusted ROE in 2024 is primarily attributable to the significant decrease in adjusted total equity, despite a moderate increase in adjusted net earnings. The negative equity position in 2025, coupled with increased adjusted net earnings, suggests a potentially volatile ROE calculation and warrants further investigation.

The volatility in adjusted ROE, particularly the large increase in 2024 and the subsequent negative equity in 2025, suggests significant changes in the company’s capital structure and profitability. These shifts require further scrutiny to understand the underlying drivers and potential implications.


Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Reported
Selected Financial Data (US$ in millions)
Net earnings attributable to AbbVie Inc.
Total assets
Profitability Ratio
ROA1
Adjusted
Selected Financial Data (US$ in millions)
Adjusted net earnings2
Adjusted total assets3
Profitability Ratio
Adjusted ROA4

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

1 2025 Calculation
ROA = 100 × Net earnings attributable to AbbVie Inc. ÷ Total assets
= 100 × ÷ =

2 Adjusted net earnings. See details »

3 Adjusted total assets. See details »

4 2025 Calculation
Adjusted ROA = 100 × Adjusted net earnings ÷ Adjusted total assets
= 100 × ÷ =


The adjusted return on assets (ROA) exhibited a fluctuating pattern over the five-year period. Initial values were relatively strong, followed by a significant decline and subsequent recovery.

Overall Trend
From 2021 to 2023, adjusted ROA decreased substantially. A low point was reached in 2023 before a recovery commenced, continuing through 2025. The adjusted ROA increased from 1.42% in 2023 to 3.60% in 2025, though it did not return to the levels observed in the earlier years of the period.
Adjusted ROA – Detailed Analysis
In 2021, the adjusted ROA stood at 7.40%. This increased slightly to 7.81% in 2022. A dramatic decrease was then observed in 2023, with the adjusted ROA falling to 1.42%. The following year, 2024, saw a partial recovery to 2.48%. The most recent year, 2025, demonstrated further improvement, reaching 3.60%.
Relationship to Underlying Components
The decline in adjusted ROA between 2021 and 2023 coincided with a decrease in adjusted net earnings, which fell from US$10,680 million to US$1,834 million. Simultaneously, adjusted total assets also decreased, but to a lesser extent. The subsequent recovery in adjusted ROA from 2024 onwards appears linked to both an increase in adjusted net earnings and a stabilization of adjusted total assets. The increase in adjusted net earnings was more pronounced than the change in adjusted total assets during the recovery period.
Comparison to Reported ROA
The adjusted ROA consistently differed from the reported ROA. The reported ROA remained higher than the adjusted ROA in each year, indicating that adjustments to net earnings and total assets resulted in a lower profitability measure. The gap between reported and adjusted ROA varied across the period, with the largest difference observed in 2023.

The fluctuations in adjusted ROA suggest potential shifts in underlying profitability or asset utilization. Further investigation into the nature of the adjustments made to net earnings and total assets would be necessary to fully understand the drivers of these changes.